These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19647880)

  • 1. Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.
    Kim HJ; Jung CG; Dukala D; Bae H; Kakazu R; Wollmann R; Soliven B
    J Neuroimmunol; 2009 Sep; 214(1-2):93-100. PubMed ID: 19647880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.
    Mullershausen F; Craveiro LM; Shin Y; Cortes-Cros M; Bassilana F; Osinde M; Wishart WL; Guerini D; Thallmair M; Schwab ME; Sivasankaran R; Seuwen K; Dev KK
    J Neurochem; 2007 Aug; 102(4):1151-61. PubMed ID: 17488279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release.
    Rolin J; Sand KL; Knudsen E; Maghazachi AA
    Cancer Immunol Immunother; 2010 Apr; 59(4):575-86. PubMed ID: 19823820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3.
    Maeda Y; Matsuyuki H; Shimano K; Kataoka H; Sugahara K; Chiba K
    J Immunol; 2007 Mar; 178(6):3437-46. PubMed ID: 17339438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
    Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
    Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo.
    Lan YY; De Creus A; Colvin BL; Abe M; Brinkmann V; Coates PT; Thomson AW
    Am J Transplant; 2005 Nov; 5(11):2649-59. PubMed ID: 16212624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration.
    Hwang SJ; Kim JH; Kim HY; Kim S; Chung DH
    Lab Invest; 2010 Jan; 90(1):9-19. PubMed ID: 19823172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo.
    Zehra Okus F; Busra Azizoglu Z; Canatan H; Eken A
    Int Immunopharmacol; 2022 Jun; 107():108665. PubMed ID: 35255303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
    J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
    Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
    Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
    Gonzalez-Cabrera PJ; Hla T; Rosen H
    J Biol Chem; 2007 Mar; 282(10):7254-64. PubMed ID: 17218309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V; Chwalla I; Siess W
    Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.
    Chun J; Hartung HP
    Clin Neuropharmacol; 2010; 33(2):91-101. PubMed ID: 20061941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
    Brinkmann V
    Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.
    Awad AS; Rouse MD; Khutsishvili K; Huang L; Bolton WK; Lynch KR; Okusa MD
    Kidney Int; 2011 May; 79(10):1090-8. PubMed ID: 21289599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools.
    Salomone S; Potts EM; Tyndall S; Ip PC; Chun J; Brinkmann V; Waeber C
    Br J Pharmacol; 2008 Jan; 153(1):140-7. PubMed ID: 18026125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
    Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
    J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants.
    Soleimani R; Heytens E; Oktay K
    PLoS One; 2011 Apr; 6(4):e19475. PubMed ID: 21559342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies?
    Köhne A; Stettner M; Jangouk P; Dehmel T; Hartung HP; Lehmann HC; Kieseier BC
    Arch Neurol; 2012 Oct; 69(10):1280-9. PubMed ID: 22751954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.